In vivo ribozyme targeting of βAPP+ mRNAs

Molecular Cell Biology Research Communications

Volumn 4, Issue 4, 2000, Pages 239-247

  Dolzhanskaya, Natalia ^a   Conti, James ^a   Merz, George ^a   Denman, Robert B ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Blue fluorescent protein (BFP); Frameshift mutant protein; Ribozyme mediated degradation; APP; APP+

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MESSENGER RNA; MUTANT PROTEIN; RIBOZYME;

ALZHEIMER DISEASE; ARTICLE; CANCER CELL; CONTROLLED STUDY; DOWN SYNDROME; EXON; FLUORESCENCE MICROSCOPY; FRAMESHIFT MUTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TARGETING; RHABDOMYOSARCOMA; SENILE PLAQUE;

EID: 0034436763     PISSN: 15224724     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcbr.2001.0287     Document Type: Article

References (36)

1. Molecular genetics of Alzheimer disease: Identification of genes and gene mutations
2. Effects of cadmium, copper, and zinc and beta-APP processing and turnover in COS-7 and PC12 cells. Relationship to Alzheimer disease pathology
3. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
4. Oxidative mechanisms in beta-amyloid cytotoxicity
5. Oxidative stress hypothesis in Alzheimer's disease
6. Frameshift mutations at two hotspots in vasopressin transcripts in post-mitotic neurons
7. Somatic mutations in the brain: Relationship to aging?
8. Mutant vasopressin precursors in the human hypothalamus: Evidence for neuronal somatic mutations in man
9. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients
10. Comparison of early markers for Alzheimer's disease type neurodegeneration within the hypothalamus
11. Hammerhead ribozyme cleavage of hamster prion pre-mRNA in Complex cell-free model systems
12. Crosslinking of the anticodon of P site bound tRNA to C-1400 of E. coli 16S RNA does not require the participation of the 50S subunit
13. RNAs that interact with the fragile X syndrome RNA binding protein FMRP
14. Self-cleaving-ribozyme-mediated reduction of βAPP in human rhabdomyosarcoma cells
15. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa
16. Multiple proteins interact at a unique cis-element in the 3′a-untranslated region of amyloid precursor protein mRNA
17. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3′-untranslated region
18. Distribution and activity of alternatively spliced Alzheimer amyloid peptide precursor and scrapie PrP mRNAs on rat brain polysomes
19. Novel cleavage of a hammerhead ribozyme targeted to beta-amyloid peptide precursor mRNA
20. Cleavage of full-length beta-APP mRNA by hammerhead ribozymes
21. A system for studying the effect(s) of familial Alzheimer disease mutations on the processing of the beta-amyloid peptide precursor
22. Ribozyme mediated degradation of beta-amyloid peptide precursor mRNA in COS-7 cells
23. Differential activity of trans-acting hammerhead ribozymes targeted to beta-amyloid peptide precursor mRNA by altering the symmetry of helices I and III
24. Facilitated reduction of beta-amyloid peptide precursor by synthetic oligonucleotides in COS-7 cells expressing a hammerhead ribozyme
25. +1 frameshift mutants
26. Design and specificity of hammerhead ribozymes against calretinin mRNA
27. Activation of HIV-specific ribozyme activity by self-cleavage
28. Evidence that alternate foldings of the hepatitis delta RNA confer varying rates of self-cleavage
29. Understanding, improving and using green fluorescent proteins
30. Selective cleavage of closely-related mRNAs by synthetic ribozymes
31. A ribozyme which discriminates in vitro between PML/RARα, the t(15;17)-associated fusion RNA of acute promyelocytic leukemia and PML and RAR α, the transcripts from nonrearranged alleles
32. Design of highly specific cytotoxins by using trans-splicing ribozymes
33. Trans-splicing ribozymes for targeted gene delivery
34. Dinucleotide deletions in neuronal transcripts: A novel type of mutation in non-familial Alzheimer's disease and Down syndrome patients